Literature DB >> 21191547

End organ damage in hypertension.

Roland E Schmieder1.   

Abstract

BACKGROUND: End organ damage in hypertension can be detected early, reflects accurately the hypertensive patient's overall cardiovascular risk, and should be prevented and treated with antihypertensive treatment.
METHOD: We selectively review the relevant literature since 1995, including the German and European guidelines for the diagnosis and treatment of arterial hypertension.
RESULTS: Measurement of the intima-media thickness in the common carotid artery and of the pulse-wave velocity is now recommended for the early diagnosis of hypertensive vasculopathy. Left ventricular hypertrophy, an important component of hypertensive heart disease, can be diagnosed by echocardiography and with the aid of new electrocardiographic indices. Early signs of hypertensive nephropathy, namely albuminuria and a decreased glomerular filtration rate, are prognostically valuable and easy to detect. Cerebrovascular damage, including early microangiopathic changes, is best diagnosed by magnetic resonance imaging. The treatment of end organ damage due to hypertension centers on blood pressure reduction. Blockade of the renin angiotensin-aldosterone system is an essential part of the treatment of early end organ damage.
CONCLUSION: Hypertensive end organ damage can now be diagnosed early and reversed with specific and aggressive treatment.

Entities:  

Mesh:

Year:  2010        PMID: 21191547      PMCID: PMC3011179          DOI: 10.3238/arztebl.2010.0866

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN: 1866-0452            Impact factor:   5.594


  47 in total

Review 1.  A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension.

Authors:  Arnfried U Klingbeil; Markus Schneider; Peter Martus; Franz H Messerli; Roland E Schmieder
Journal:  Am J Med       Date:  2003-07       Impact factor: 4.965

2.  Survival and recurrent strokes in patients with different subtypes of stroke: a fourteen-year follow-up study.

Authors:  S E Eriksson; J E Olsson
Journal:  Cerebrovasc Dis       Date:  2001       Impact factor: 2.762

3.  Effect of obesity on electrocardiographic left ventricular hypertrophy in hypertensive patients : the losartan intervention for endpoint (LIFE) reduction in hypertension study.

Authors:  P M Okin; S Jern; R B Devereux; S E Kjeldsen; B Dahlöf
Journal:  Hypertension       Date:  2000-01       Impact factor: 10.190

4.  Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Authors: 
Journal:  JAMA       Date:  2002-12-18       Impact factor: 56.272

5.  Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial.

Authors:  J F Mann; H C Gerstein; J Pogue; J Bosch; S Yusuf
Journal:  Ann Intern Med       Date:  2001-04-17       Impact factor: 25.391

6.  Reliability of echocardiographic assessment of left ventricular structure and function: the PRESERVE study. Prospective Randomized Study Evaluating Regression of Ventricular Enlargement.

Authors:  V Palmieri; B Dahlöf; V DeQuattro; N Sharpe; J N Bella; G de Simone; M Paranicas; D Fishman; R B Devereux
Journal:  J Am Coll Cardiol       Date:  1999-11-01       Impact factor: 24.094

7.  Atrial fibrillation in hypertension: predictors and outcome.

Authors:  Paolo Verdecchia; GianPaolo Reboldi; Roberto Gattobigio; Maurizio Bentivoglio; Claudia Borgioni; Fabio Angeli; Erberto Carluccio; Maria Grazia Sardone; Carlo Porcellati
Journal:  Hypertension       Date:  2003-02       Impact factor: 10.190

8.  Changes in cardiovascular risk by reduction of left ventricular mass in hypertension: a meta-analysis.

Authors:  Paolo Verdecchia; Fabio Angeli; Claudia Borgioni; Roberto Gattobigio; Gianni de Simone; Richard B Devereux; Carlo Porcellati
Journal:  Am J Hypertens       Date:  2003-11       Impact factor: 2.689

9.  Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies.

Authors:  Sarah Lewington; Robert Clarke; Nawab Qizilbash; Richard Peto; Rory Collins
Journal:  Lancet       Date:  2002-12-14       Impact factor: 79.321

10.  New gender-specific partition values for ECG criteria of left ventricular hypertrophy: recalibration against cardiac MRI.

Authors:  Khaled Alfakih; Kevin Walters; Tim Jones; John Ridgway; Alistair S Hall; Mohan Sivananthan
Journal:  Hypertension       Date:  2004-06-28       Impact factor: 10.190

View more
  49 in total

1.  Anesthetic management for percutaneous computed tomography-guided radiofrequency ablation of reninoma: a case report.

Authors:  Nam-Su Gil; Jeong Yeol Han; Seong-Ho Ok; Il-Woo Shin; Heon Keun Lee; Young-Kyun Chung; Ju-Tae Sohn
Journal:  Korean J Anesthesiol       Date:  2015-01-28

2.  2017 ACC/AHA blood pressure classification and incident peripheral artery disease: The Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Yifei Lu; Shoshana H Ballew; Hirofumi Tanaka; Moyses Szklo; Gerardo Heiss; Josef Coresh; Kunihiro Matsushita
Journal:  Eur J Prev Cardiol       Date:  2019-07-30       Impact factor: 7.804

3.  Interleukin-6 inhibition attenuates hypertension and associated renal damage in Dahl salt-sensitive rats.

Authors:  Shireen Hashmat; Nathan Rudemiller; Hayley Lund; Justine M Abais-Battad; Scott Van Why; David L Mattson
Journal:  Am J Physiol Renal Physiol       Date:  2016-06-08

4.  [End-organ damages in diabetes].

Authors:  H Haller; B E Strauer
Journal:  Internist (Berl)       Date:  2011-05       Impact factor: 0.743

5.  Retinopathy as a differential diagnosis.

Authors:  Dieter Schmidt
Journal:  Dtsch Arztebl Int       Date:  2011-03-18       Impact factor: 5.594

6.  Not very meaningful.

Authors:  Thomas Schneider
Journal:  Dtsch Arztebl Int       Date:  2011-03-18       Impact factor: 5.594

Review 7.  Surgical, interventional, and device innovations in the management of hypertension.

Authors:  Sibu P Saha; Khaled M Ziada; Thomas F Whayne
Journal:  Int J Angiol       Date:  2015-03

8.  Influence of doxazosin on biosynthesis of S100A6 and atrial natriuretic factor peptides in the heart of spontaneously hypertensive rats.

Authors:  Irena Kasacka; Żaneta Piotrowska; Anna Filipek; Mariusz Majewski
Journal:  Exp Biol Med (Maywood)       Date:  2015-10-28

9.  Effects of Hatha yoga on blood pressure, salivary α-amylase, and cortisol function among normotensive and prehypertensive youth.

Authors:  John C Sieverdes; Martina Mueller; Mathew J Gregoski; Brenda Brunner-Jackson; Lisa McQuade; Cameron Matthews; Frank A Treiber
Journal:  J Altern Complement Med       Date:  2014-03-12       Impact factor: 2.579

10.  Association Between Long-Term Blood Pressure Variability and 10-Year Progression in Arterial Stiffness: The Multiethnic Study of Atherosclerosis.

Authors:  Yacob G Tedla; Yuichiro Yano; Mercedes Carnethon; Philip Greenland
Journal:  Hypertension       Date:  2016-11-14       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.